Somatropin (rbe)
Consumer Medicine Information
What is in this leaflet
This leaflet answers some common questions about Norditropin® FlexPro®. It does not contain all the available information. It does not take the place of
talking to your doctor or pharmacist.
All medicines have risks and benefits. Your doctor has weighed the risks of you or
your child using Norditropin® FlexPro® against the benefits they expect it will have.
If you have any concerns about using this medicine, ask your doctor or pharmacist.
Keep this leaflet with the medicine.
You may need to read it again.
What Norditropin® FlexPro® is used for
Norditropin® FlexPro® is a pre-filled dial-a-dose pen containing Norditropin®, a solution of human growth hormone. Norditropin® [also called somatropin (rbe)], is used to treat:
1. growth failure in children, which may be due to:
a condition called Growth Hormone Deficiency, where the gland at the base of the brain
(pituitary gland) does not make enough growth hormone
a condition called either Small for Gestational Age (SGA) or Intrauterine Growth Retardation
(IUGR), where growth failure started during the mother’s pregnancy. Children with
SGA/IUGR do not lack growth hormone and are therefore not treated for growth hormone
deficiency. Treatment with Norditropin® FlexPro® promotes catch-up growth and increases final height.
Chronic kidney disease
Turner syndrome, a genetic condition in girls
2. growth hormone deficiency in adults
You or your child may have been prescribed Norditropin® FlexPro® for another reason.
Ask your doctor if you have any questions about why Norditropin® FlexPro® has been prescribed for you or your child.
There is no evidence that Norditropin® is addictive.
Before using Norditropin® FlexPro®
When you or your child must not use it
You or your child should not use Norditropin® FlexPro® if you/your child:
are allergic to phenol or any other ingredient listed in the ingredient section of
this leaflet.
Some of the symptoms of an allergic reaction may include:
rash
wheezing
swelling of the eyelids, face or lips
complete collapse
have cancer or another form of active tumour
have not finished treatment for cancer or another form of tumour
have slow growth for reasons other than a lack of growth hormone, except where specific
uses are described above
have had a kidney transplant in the last 12 months or have had more than one episode
of acute rejection (ask your doctor if unsure what this means)
have an acute critical illness due to complications following open heart or abdominal
surgery or multiple accident trauma
have acute respiratory failure
Do not use Norditropin® FlexPro® if:
it is after the expiry date (Expiry) printed on the label and carton
the packaging is torn, shows signs of tampering or does not look quite right
the solution is cloudy or discoloured.
Before you or your child starts to use it
Tell your doctor if you or your child has any medical conditions, especially the following:
diabetes
cancer or any other kind of tumour
impaired kidney function
severe or recurring headaches, visual problems, nausea and vomiting. These may be
symptoms of raised pressure of the fluid around the brain.
tiredness, lethargy, muscle weakness, cramps, feeling the cold, a slow heart rate,
dry and flaky skin, hair loss, a deep and husky voice and weight gain. These may be
signs and symptoms of hypothyroidism (an underactive thyroid gland causing a decrease
in metabolism).
development of curvature in the spine (scoliosis) in your child
if your child has Turner syndrome and:
you notice increased growth of your child’s hands and feet that is not in proportion
to their height, or
they develop an ear infection.
Norditropin® may cause an inflammation of the pancreas, which causes severe pain in the abdomen
and back. Contact your doctor if you or your child develops stomach aches after taking
Norditropin®.
If any of the above applies, Norditropin® FlexPro® may not be suitable. Your doctor will give you advice.
Your doctor will measure your child’s height and weight before he or she is prescribed
Norditropin® FlexPro®. If you or your child is growth hormone deficient, your doctor will also need to
measure your/their ability to produce growth hormone.
If you or your child is using Norditropin® FlexPro® due to growth problems associated with a kidney disease, it is important to continue
with any treatment for the kidney condition while Norditropin® FlexPro® is being used.
As growth hormone can affect blood sugar levels, your doctor may perform regular blood
checks on you or your child.
Taking other medicines
Tell your doctor if you or your child is taking any other medicines, including any
that you buy without a prescription from a pharmacy, supermarket or health food shop.
Some medicines may interfere with the growth effect of Norditropin®. These include:
glucocorticoids
sex steroids
thyroid hormone
If you are unsure whether you or your child is taking these medicines talk to your
doctor or pharmacist.
If you or your child is being treated with insulin, the dosage of insulin may have
to be adjusted.
If you have not told your doctor about any of the above, tell them before you or your
child use Norditropin® FlexPro®.
Pregnancy and breast-feeding
Tell your doctor if you are pregnant or plan to become pregnant or are breast-feeding.
Your doctor can discuss with you the risks and benefits involved.
There is no information on the effects of Norditropin® during pregnancy or breast-feeding.
Norditropin® FlexPro® should be used during pregnancy only if clearly needed.
Using Norditropin® FlexPro®
How much to use
Your doctor will tell you how much Norditropin® you or your child should use. It depends on factors such as body weight and body
surface area.
How and when to use it
Norditropin® is given as an injection with Norditropin® FlexPro® under the skin in the evening, 6 or 7 days per week. Injection sites should be varied
as shown to you by your doctor or other healthcare professional. This will lessen
the risk of damage to the fat and tissues under the skin (lipodystrophy).
NovoFine® needles (8 mm 30 G or smaller) are designed to be used with Norditropin® FlexPro®.
Follow the detailed instructions on how to use Norditropin® FlexPro® in the Instructions For Use supplied with the product.
These instructions are also available via the following hyperlinks:
http://medsinfo.com.au/media/noinor05
http://medsinfo.com.au/media/noinor10
http://medsinfo.com.au/media/noinor15
If you have any questions or concerns about how to use Norditropin® FlexPro® talk to your doctor or pharmacist.
Norditropin® FlexPro® is prescribed for you or your child’s personal use only.
Do not give it to anyone else.
How long to use it
You or your child may stop using Norditropin® FlexPro® at any time. Before doing so, you should discuss this first with your doctor.
If you are unsure how long to use Norditropin® FlexPro®, talk to your doctor.
If you or your child misses a dose
Inject the next dose as normal the next evening. Do not inject extra to make up for
the missed dose.
If you or your child uses too much (overdose)
If you inject too much Norditropin®, contact your doctor.
You or your child should not inject more Norditropin® than the doctor has prescribed, as it may increase the risk of side effects.
Long term overdosage could result in signs and symptoms of growth hormone excess.
Extreme growth hormone excess can result in overgrowth of bones and enlargement of
hands and feet.
While you or your child is using Norditropin® FlexPro®
Things you must not do
Do not give Norditropin® FlexPro® to anyone else, even if they have the same condition as you or your child.
Do not use Norditropin® FlexPro® to treat any other complaints unless your doctor tells you to.
Do not stop using Norditropin® FlexPro® or lower the dosage, without first checking with your doctor.
Do not shake Norditropin® FlexPro® vigorously at any time. It should be handled with care.
Things to be careful of
Tell your doctor if you or your child is scheduled to have surgery.
If you or your child has a kidney condition, your doctor will closely monitor the
kidney function (how well the kidneys are working). If there is any decrease in function,
it may be necessary to stop using Norditropin®.
Side effects
All medicines can have side effects. Sometimes they are serious, most of the time
they are not.
Tell your doctor or pharmacist as soon as possible if you or your child do not feel
well while using Norditropin® FlexPro®. Ask your doctor or pharmacist to answer any questions you may have.
Tell your doctor or pharmacist if you notice any of the following and they worry you:
breast enlargement
swollen hands and feet due to fluid retention
redness and itching around the area you inject. Some patients may develop local skin
reactions at the injection site which appear and disappear during treatment. If you
inject too often in the same small area, damage may occur to the fat and tissues under
the skin (lipodystrophy).
The above list includes the more common side effects of Norditropin® FlexPro®. They are usually mild and temporary.
Tell your doctor as soon as possible if you notice any of the following:
joint and muscle pain
skin rash
headache
curvature of the spine
fluid retention
If you or your child experiences any of these symptoms, the dosage of Norditropin® may need to be reduced. Discuss this with your doctor.
If any of the following happen, tell your doctor immediately or go to Accident and
Emergency at your nearest hospital:
allergic reaction. Symptoms of this may include rash; wheezing; swelling of the eyelids,
face or lips; complete collapse.
benign raised pressure of the fluid around the brain. Symptoms of this can include
severe or recurring headaches, problems with eye sight, feeling sick or vomiting.
The above list includes serious side effects. You may need urgent medical attention.
These side effects are very rare.
In rare cases, the body may form antibodies to Norditropin®. These antibodies could
reduce further growth with Norditropin® treatment.
In very rare cases, children treated with growth hormone have felt pain in the hip
or knee, or have experienced limping. These symptoms may be caused by Legg-Calvé-Perthes
disease (disease at the top of the thigh bone) or slipped capital femoral epiphysis
(the end of the bone slips from the cartilage) and may not be due to the medicine.
In a small number of patients treated with growth hormone, cancer, including leukaemia
or relapse of brain tumours, or raised levels of glucose in the blood (a condition
called 'impaired glucose tolerance' (IGT)) have been reported. However, there is no
evidence that growth hormone is responsible for causing these conditions.
If you think that you or your child are suffering from any of these symptoms or from
any other side effects not mentioned here, speak to your doctor or pharmacist.
Do not be alarmed by this list of possible side effects.
You or your child may not experience any of them.
Storage
Store unused Norditropin® FlexPro® pens in a refrigerator (2°C-8°C) in the outer carton to protect them from light.
Do not use if frozen. Do not freeze or expose to heat. Do not store close to any cooling
elements.
Always keep the pen cap fully closed on Norditropin® FlexPro® when you are not using it.
While using Norditropin® FlexPro® you can either:
Keep it for up to 4 weeks in a refrigerator (2°C to 8°C),
or
Keep it for up to 3 weeks at room temperature (below 25°C).
Keep out of the reach of children.
Do not use Norditropin® FlexPro® which has been frozen or exposed to excess heat.
Never use Norditropin® FlexPro® after the expiry date printed on the label and carton.
The expiry date refers to the last day of that month.
Disposal
If your doctor tells you or your child to stop using Norditropin® FlexPro®, or the medicine has passed its expiry date, return any unused medicine to your pharmacist
for disposal.
Product Description
What it looks like
The Norditropin® in Norditropin® FlexPro® is a clear, colourless solution for subcutaneous injection contained in a multi-dose,
disposable 1.5 mL pre-filled pen.
Norditropin® FlexPro® 5 mg/1.5 mL has a yellow push button, pen cap and cartridge holder. It delivers a
maximum dose of 2.0 mg per dose, in increments of 0.025 mg somatropin.
Norditropin® FlexPro® 10 mg/1.5 mL has a blue push button, pen cap and cartridge holder. It delivers a
maximum of 4.0 mg per dose, in increments of 0.050 mg somatropin.
Norditropin® FlexPro® 15 mg/1.5 mL has a green push button, pen cap and cartridge holder. It delivers a
maximum dose of 8.0 mg per dose in increments of 0.1 mg somatropin.
Norditropin® FlexPro® is for use with NovoFine® needles (8 mm 30 G or smaller).
Ingredients
The Norditropin® in Norditropin® FlexPro® contains the active ingredient biosynthetic human growth hormone, which is called
somatropin (rbe). It is identical to the growth hormone produced in the human body.
The abbreviation 'rbe' indicates the method of genetic engineering used to manufacture
the growth hormone.
Other ingredients in Norditropin® FlexPro® are: mannitol, histidine, poloxamer, phenol and water for injections. The quantity
of each ingredient is on the label of the carton.
Manufacturer
Norditropin® FlexPro® is supplied in Australia by:
Novo Nordisk Pharmaceuticals Pty. Ltd.
Level 10, 118 Mount Street, North Sydney NSW 2060, Australia
This leaflet was prepared in March 2022
Australian Registration Number:
Norditropin® FlexPro® 5mg: AUST R 173396
Norditropin®, FlexPro® and NovoCare® are registered trademarks of Novo Nordisk Health Care AG. NovoFine® is a registered trademark of Novo Nordisk A/S.
© 2022
Novo Nordisk A/S
2880 Bagsvaerd, Denmark
Further information
For further information call the NovoCare® Customer Care Centre on 1800 668 626.
www.novonordisk.com.au
Current 'Product Information' documents are available from the following websites:
www.novonordisk.com.au (AU)
https://www.ebs.tga.gov.au/ (AU)